We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$369M
AUM Growth
-$418K
Cap. Flow
-$12.4M
Cap. Flow %
-3.37%
Top 10 Hldgs %
23.09%
Holding
244
New
26
Increased
87
Reduced
73
Closed
45

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$3.02M
2
PFE icon
Pfizer
PFE
+$3M
3
CVS icon
CVS Health
CVS
+$2.72M
4
KHC icon
Kraft Heinz
KHC
+$2.68M
5
EXC icon
Exelon
EXC
+$2.67M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$3.8M
2
FUN icon
Cedar Fair
FUN
+$2.55M
3
AZN icon
AstraZeneca
AZN
+$2.41M
4
GSK icon
GSK
GSK
+$2.38M
5
PPL
PPL Corp
PPL
+$2.23M

Sector Composition

Rank Sector Weight
1 Technology 14.63%
2 Healthcare 14.59%
3 Consumer Staples 11.98%
4 Industrials 10.74%
5 Utilities 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
126
Merck
MRK
$315B
$622K 0.17%
10,173
– –
BSTC
127
DELISTED
BioSpecifics Technologies Corp.
BSTC
$621K 0.17%
12,546
-2,343
-16% -$123K
CMT icon
128
Core Molding Technologies
CMT
$213M
$618K 0.17%
28,575
+907
+3% +$18K
TWX
129
DELISTED
Time Warner Inc
TWX
$617K 0.17%
6,144
+121
+2% +$12K
AMGN icon
130
Amgen
AMGN
$198B
$615K 0.17%
3,573
-20
-0.6% -$3.25K
ELV icon
131
Elevance Health
ELV
$80.9B
$613K 0.17%
3,256
+25
+0.8% +$4.49K
GPK icon
132
Graphic Packaging
GPK
$3.2B
$591K 0.16%
42,879
-91
-0.2% -$1.22K
PARA
133
DELISTED
Paramount Global Class B
PARA
$587K 0.16%
9,201
+127
+1% +$8.13K
FONR
134
DELISTED
Fonar
FONR
$585K 0.16%
21,077
+1,890
+10% +$43.4K
PRGS icon
135
Progress Software
PRGS
$1.66B
$585K 0.16%
18,935
+318
+2% +$9.42K
AMWD
136
DELISTED
American Woodmark
AMWD
$580K 0.16%
6,067
+433
+8% +$39.7K
MPC icon
137
Marathon Petroleum
MPC
$91.3B
$576K 0.16%
11,016
-111
-1% -$5.73K
GSB
138
DELISTED
GlobalSCAPE, Inc.
GSB
$575K 0.16%
108,650
-2,000
-2% -$8.81K
UNM icon
139
Unum
UNM
$14.2B
$566K 0.15%
12,131
+171
+1% +$7.87K
MXIM
140
DELISTED
Maxim Integrated Products
MXIM
$562K 0.15%
12,518
-3
-0% -$138
HXL icon
141
Hexcel
HXL
$7.83B
$555K 0.15%
10,508
+896
+9% +$46.3K
BNS icon
142
Scotiabank
BNS
$110B
$554K 0.15%
9,206
+39
+0.4% +$2.23K
AMAT icon
143
Applied Materials
AMAT
$421B
$550K 0.15%
13,305
+199
+2% +$8.46K
LABL
144
DELISTED
Multi-Color Corp
LABL
$545K 0.15%
6,675
+870
+15% +$68.7K
WINA icon
145
Winmark
WINA
$1.39B
$542K 0.15%
4,201
+373
+10% +$47.2K
ZIXI
146
DELISTED
Zix Corporation
ZIXI
$539K 0.15%
94,645
-2,814
-3% -$15.8K
MTB icon
147
M&T Bank
MTB
$36.1B
$537K 0.15%
3,316
+94
+3% +$14.8K
HF
148
DELISTED
HFF Inc.
HF
$531K 0.14%
15,275
+178
+1% +$5.48K
VLO icon
149
Valero Energy
VLO
$91.9B
$529K 0.14%
7,840
-456
-5% -$29.6K
FLXS icon
150
Flexsteel Industries
FLXS
$297M
$512K 0.14%
9,458
+230
+2% +$12.1K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q2 2017 Portfolio in Review

As of Q2 2017, Stanley-Laman Group held 244 positions worth $369M, down 0.11% from $369M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Stanley-Laman Group withdrew a net $12.4M in Q2 2017, closing 45 positions and reducing 73 holdings. Its most notable exit was Cedar Fair, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Stanley-Laman Group opened a new position in Altria Group worth $3.07M.

  • Stanley-Laman Group's largest Q2 2017 buy was Altria Group: 41,225 shares worth $3.07M.
  • Stanley-Laman Group added most to Pfizer in Q2 2017, an estimated $3M increase.
  • Stanley-Laman Group's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $3.8M.
  • Stanley-Laman Group fully exited Cedar Fair in Q2 2017, selling an estimated $2.55M.
  • Stanley-Laman Group's ten largest holdings make up 23% of its $369M portfolio in Q2 2017.
  • Stanley-Laman Group opened 26 new positions and closed 45 in Q2 2017.
  • Stanley-Laman Group's portfolio value fell 0.11% quarter-over-quarter to $369M.

Based on Stanley-Laman Group's 13F filing for Q2 2017, filed 7 Aug 2017.